RxDoctor Payments Data

Ashley Dorton, PA

Physician Assistant · Muskegon, MINPI 1003300310

Payments from drug & device makers

$1,399in general payments, 2019–2025

Across 57 payments — averaging $24.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$193
  • Atricure, Inc.$189
  • Medtronic$160
  • Boehringer Ingelheim$159
  • Amgen$125
  • Preventice Services, LLC$72
  • plus $501 from 15 others

What the payments were for

  • Food & beverage$1,399100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,399 in reported general payments places this provider in the 80th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$7,584
Medicare patients
100
Services billed
118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban94$96,789
EntrestoSacubitril/Valsartan39$49,347
Repatha SureclickEvolocumab22$21,632
FarxigaDapagliflozin Propanediol15$13,713
Metoprolol Succinate175$3,283
Ranolazine ErRanolazine26$2,241
Rosuvastatin Calcium37$1,081
Isosorbide Mononitrate ErIsosorbide Mononitrate45$821
Amiodarone Hcl31$819
Carvedilol55$748
ClopidogrelClopidogrel Bisulfate40$668
Losartan Potassium41$552
Atorvastatin Calcium40$424
Prasugrel Hcl13$414
SotalolSotalol Hcl14$389

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$31$96,78994 claims
NovartisEntresto$193$49,34739 claims
AstraZenecaFarxiga$46$13,71315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Muskegon

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →